Bezafibrate
Back to searchMolecule Structure
Scientific Name
Bezafibrate
Description of the Drug
Bezafibrate is a lipid-lowering fibrate used in the management of primary and secondary hyperlipidaemia, when there is a lack of clinical improvement following lifestyle modifications or correction of the underlying disorder.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01393
http://www.drugbank.ca/drugs/DB01393
Brand Name(s)
Bezagen xl, Bezalip, Bezalip-mono, Fibrazate xl, Liparol xl, Zimbacol xl
Company Owner(s)
Not Available
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Peroxisome proliferator-activated receptor | PROTEIN FAMILY | AGONIST | CHEMBL3559683 |
Clinical Trial(s)
Unichem Links
Atlas | bezafibrate |
SureChEMBL | SCHEMBL16299 |
PharmGKB | PA162364313 |
Human Metabolome Database | HMDB0015465 |
DrugBank | DB01393 |
PubChem: Thomson Pharma | 14926008 |
PubChem | 39042 |
Mcule | MCULE-9775992840 |
LINCS | LSM-3015 |
Nikkaji | J16.626J |
PDBe | PEM |
BindingDB | 28701 |
EPA CompTox Dashboard | DTXSID3029869 |
DrugCentral | 362 |
Brenda | 105590 |
ChemicalBook | CB1188501 |
Guide to Pharmacology | 2668 |
rxnorm | BEZAFIBRATE |
PubChem: Drugs of the Future | 12015374 |
ChEBI | 47612 |
ZINC | ZINC000003956919 |